{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:26:23Z","timestamp":1767853583176,"version":"3.49.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Alkermes, Inc"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.neuropharm.2018.11.015","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T11:57:30Z","timestamp":1542283050000},"page":"316-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2865-2823","authenticated-orcid":false,"given":"Karen L.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacobi I.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Eyerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Reginald L.","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R.","family":"Deaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.11.015_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/PPA.S29716","article-title":"Treatment-resistant depression: therapeutic trends, challenges, and future directions","volume":"6","author":"Al-Harbi","year":"2012","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/0269881115586937","article-title":"Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice","volume":"29","author":"Almatroudi","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib3","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0306-4530(95)00018-6","article-title":"Comparison of the behavioural and endocrine response to forced swimming stress in five inbred strains of rats","volume":"20","author":"Armario","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archpsyc.1989.01810030049007","article-title":"Reduction of prefrontal cortex glucose metabolism common to three types of depression","volume":"46","author":"Baxter","year":"1989","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.psyneuen.2014.12.004","article-title":"Opioid partial agonist buprenorphine dampens responses to psychosocial stress in humans","volume":"52","author":"Bershad","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/ijnp\/pyx077","article-title":"Effects of buprenorphine on responses to emotional stimuli in individuals with a range of mood symptomatology","volume":"21","author":"Bershad","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.psyneuen.2015.09.011","article-title":"Effects of buprenorphine on responses to social stimuli in healthy adults","volume":"63","author":"Bershad","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/j.neuropharm.2018.11.015_bib91","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/jpet.118.249839","article-title":"In vitro pharmacological characterization of buprenorphine, samidorphan, and combinations being developed as an adjunctive treatment of major depressive disorder","volume":"367","author":"Bidlack","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004714-199502000-00008","article-title":"Buprenorphine treatment of refractory depression","volume":"15","author":"Bodkin","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1017\/S1461145710000994","article-title":"Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders","volume":"14","author":"Bravo","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2018.11.015_bib10","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ijnp\/pyx079","article-title":"Reversal of stress-induced social interaction deficits by buprenorphine","volume":"21","author":"Browne","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbr.2014.10.014","article-title":"Antidepressant-like effects of buprenorphine in rats are strain dependent","volume":"278","author":"Browne","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib12","doi-asserted-by":"crossref","first-page":"29803","DOI":"10.1074\/jbc.M705540200","article-title":"Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase","volume":"282","author":"Bruchas","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.physbeh.2016.08.031","article-title":"Sex differences and similarities in depressive- and anxiety-like behaviour in the Wistar-Kyoto rat","volume":"167","author":"Burke","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib92","unstructured":"Burke, N. (2018; February 9) personal communication."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00213-010-1832-9","article-title":"Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats","volume":"210","author":"Carr","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.31887\/DCNS.2002.4.3\/gcassano","article-title":"Psychopharmacology of anxiety disorders","volume":"4","author":"Cassano","year":"2002","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib16","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1460-9568.2009.06827.x","article-title":"Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms","volume":"30","author":"Chefer","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib17","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Council","year":"2011"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib18","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbr.2016.07.017","article-title":"Exposure to morphine-associated cues increases mu opioid receptor mRNA expression in the nucleus accumbens of Wistar Kyoto rats","volume":"313","author":"Dennis","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib19","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S0022-3565(25)39324-9","article-title":"Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies","volume":"266","author":"Devine","year":"1993","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib20","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0022-3565(25)24578-5","article-title":"Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats","volume":"244","author":"Di Chiara","year":"1988","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib21","first-page":"171","article-title":"Preferential stimulation of dopamine release in the mesolimbic system: a common feature of drugs of abuse","author":"Di Chiara","year":"1987","journal-title":"Neurotransmitter Interact. Basal Ganglia"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib22","first-page":"261","article-title":"Neuroanatomical circuits in depression: implications for treatment mechanisms","volume":"28","author":"Drevets","year":"1992","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib23","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1523\/JNEUROSCI.12-09-03628.1992","article-title":"A functional anatomical study of unipolar depression","volume":"12","author":"Drevets","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib24","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/npp.2014.330","article-title":"Evaluation of opioid modulation in major depressive disorder","volume":"40","author":"Ehrich","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib25","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/npp.2016.38","article-title":"Antidepressant-like effects of buprenorphine are mediated by kappa opioid receptors","volume":"41","author":"Falcon","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00213-014-3723-y","article-title":"Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice","volume":"232","author":"Falcon","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib27","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1227\/NEU.0b013e3182237346","article-title":"An evaluation of neuroplasticity and behavior after deep brain stimulation of the nucleus accumbens in an animal model of depression","volume":"69","author":"Falowski","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1176\/appi.ajp.2015.15070921","article-title":"Opioid modulation with buprenorphine\/samidorphan as adjunctive treatment for inadequate response to antidepressants: a randomized double-blind placebo-controlled trial","volume":"173","author":"Fava","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0193-953X(02)00107-7","article-title":"Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study","volume":"26","author":"Fava","year":"2003","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib30","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.neuroscience.2004.10.016","article-title":"The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals","volume":"130","author":"Fusa","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib31","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00213-008-1112-0","article-title":"Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone","volume":"198","author":"Glover","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000126973","article-title":"Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level","volume":"63","author":"Gomez","year":"1996","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0031-9384(98)00298-4","article-title":"Behavioral effects of acute and chronic fluoxetine in Wistar-Kyoto rats","volume":"67","author":"Griebel","year":"1999","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0014-2999(93)90980-V","article-title":"Lack of cross-tolerance between U69,593 and bremazocine suggests kappa-opioid receptor multiplicity in mice","volume":"239","author":"Horan","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib35","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)29586-0","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist","volume":"297","author":"Huang","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib36","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.psyneuen.2012.05.002","article-title":"Reduced fear-recognition sensitivity following acute buprenorphine administration in healthy volunteers","volume":"38","author":"Ipser","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1523\/JNEUROSCI.12-02-00483.1992","article-title":"Opioids excite dopamine neurons by hyperpolarization of local interneurons","volume":"12","author":"Johnson","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0014-2999(92)90055-9","article-title":"Long term kappa-opioid receptor blockade following nor-binaltorphimine","volume":"215","author":"Jones","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/adb.12163","article-title":"Abuse potential of intranasal buprenorphine versus buprenorphine\/naloxone in buprenorphine-maintained heroin users","volume":"20","author":"Jones","year":"2015","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/mi.6.3.7","article-title":"The antidepressant -like effects of delta-opioid receptor agonists","volume":"6","author":"Jutkiewicz","year":"2006","journal-title":"Mol. Interv."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib41","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.4088\/JCP.13m08725","article-title":"Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults","volume":"75","author":"Karp","year":"2014","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib42","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0091-3057(78)90051-5","article-title":"Enkephalin and other peptides reduce passiveness","volume":"9","author":"Kastin","year":"1978","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib43","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/0706743716659416","article-title":"Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. Disease burden and principles of care","volume":"61","author":"Lam","year":"2016","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib44","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0028-3908(87)90112-2","article-title":"Buprenorphine has potent kappa opioid receptor antagonist activity","volume":"26","author":"Leander","year":"1987","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0893-133X(99)00100-1","article-title":"Strain differences in the behavioral effects of antidepressant drugs in the rat forced swimming test","volume":"22","author":"Lopez-Rubalcava","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib46","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.conb.2013.02.005","article-title":"The multiple facets of opioid receptor function: implications for addiction","volume":"23","author":"Lutz","year":"2013","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","article-title":"Opioid receptors: distinct roles in mood disorders","volume":"36","author":"Lutz","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib48","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0304-3940(94)90559-2","article-title":"U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats","volume":"181","author":"Maisonneuve","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib50","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbr.2006.09.017","article-title":"Aggressive behavior and HPA axis hormones after social isolation in adult rats of two different genetic animal models for depression","volume":"175","author":"Malkesman","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib51","first-page":"2445","article-title":"Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain","volume":"7","author":"Mansour","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0166-2236(88)90093-8","article-title":"Anatomy of CNS opioid receptors","volume":"11","author":"Mansour","year":"1988","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib53","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1124\/mol.111.074195","article-title":"Duration of action of a broad range of selective kappa-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation","volume":"80","author":"Melief","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib54","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.neubiorev.2013.01.008","article-title":"Depressive disorders and suicide: epidemiology, risk factors, and burden","volume":"37","author":"Miret","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fnbeh.2014.00109","article-title":"Learned helplessness and social avoidance in the Wistar-Kyoto rat","volume":"8","author":"Nam","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib56","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00008877-200211000-00005","article-title":"Delta opioid antagonist effects of buprenorphine in rhesus monkeys","volume":"13","author":"Negus","year":"2002","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib57","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/JCP.0b013e31818638a4","article-title":"Opiate treatment in depression refractory to antidepressants and electroconvulsive therapy","volume":"28","author":"Nyhuis","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib58","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0031-9384(89)90025-5","article-title":"\u201cBehavioral despair\u201d test predicts stress ulcer in WKY rats","volume":"46","author":"Pare","year":"1989","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib59","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.biopsych.2011.05.021","article-title":"Repeated exposure to the kappa-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity","volume":"70","author":"Potter","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib60","doi-asserted-by":"crossref","first-page":"S781","DOI":"10.1016\/S0924-977X(17)31422-0","article-title":"Altered circuit function and plasticity in the hippocampus and prefrontal cortex of an animal model of treatment-resistant depression","volume":"27","author":"Puryear","year":"2017","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib61","first-page":"R353","article-title":"Strain differences in hypothalamic-pituitary-adrenal activity and stress ulcer","volume":"266","author":"Redei","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0091-3057(94)90484-7","article-title":"Dissociation of buprenorphine-induced locomotor sensitization and conditioned place preference in rats","volume":"49","author":"Rowlett","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0925-4927(95)02594-N","article-title":"Regional cerebral blood flow in mood disorders: IV. Comparison of mania and depression","volume":"61","author":"Rubin","year":"1995","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib64","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archpsyc.1996.01830040028005","article-title":"The role of psychotherapy in the treatment of depression: review of two practice guidelines","volume":"53","author":"Rush","year":"1996","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib65","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/archpsyc.65.8.870","article-title":"Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features","volume":"65","author":"Rush","year":"2008","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib66","first-page":"S473","article-title":"W119. Mu dependent effects of buprenorphine in combination with samidorphan on immobility behavior in wistar Kyoto rats","author":"Smith KL","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib67","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(85)91326-5","article-title":"Changes of serotonin and dopamine metabolism in various forebrain areas of rats injected with morphine either systemically or in the raphe nuclei dorsalis and medianus","volume":"328","author":"Spampinato","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib68","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/j.1471-4159.1990.tb04963.x","article-title":"The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study","volume":"55","author":"Spanagel","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib69","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/pr.109.001933","article-title":"Drug wanting: behavioral sensitization and relapse to drug-seeking behavior","volume":"63","author":"Steketee","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib70","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0006-8993(02)02894-9","article-title":"Kappa-Opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex","volume":"946","author":"Svingos","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib71","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0306-4522(95)00154-B","article-title":"Involvement of the dorsal raphe but not median raphe nucleus in morphine-induced increases in serotonin release in the rat forebrain","volume":"68","author":"Tao","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib72","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/jpet.102.037861","article-title":"Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system","volume":"303","author":"Tao","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0278-5846(02)00308-1","article-title":"Strain-dependent modification of behavior following antidepressant treatment","volume":"27","author":"Tejani-Butt","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib74","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/npp.2013.76","article-title":"Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion","volume":"38","author":"Tejeda","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib75","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10550880802122646","article-title":"Psychotherapeutic benefits of opioid agonist therapy","volume":"27","author":"Tenore","year":"2008","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib76","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.3399\/bjgp13X675430","article-title":"Prevalence of treatment-resistant depression in primary care: cross-sectional data","volume":"63","author":"Thomas","year":"2013","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib77","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-003-1680-y","article-title":"Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats","volume":"172","author":"Todtenkopf","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib78","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.4088\/JCP.v67n0919","article-title":"Use of treatment algorithms for depression","volume":"67","author":"Trivedi","year":"2006","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib79","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.bmcl.2009.02.078","article-title":"Syntheses of novel high affinity ligands for opioid receptors","volume":"19","author":"Wentland","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib80","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bmcl.2008.10.134","article-title":"Syntheses and opioid receptor binding properties of carboxamido-substituted opioids","volume":"19","author":"Wentland","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib81","series-title":"Depression and Other Common Mental Disorders: Global Health Estimates","author":"WHO","year":"2017"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib82","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.mp.4001345","article-title":"Selectively bred Wistar-Kyoto rats: an animal model of depression and hyper-responsiveness to antidepressants","volume":"8","author":"Will","year":"2003","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib83","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/7854_2009_27","article-title":"Dopamine signaling in the nucleus accumbens of animals self-administering drugs of abuse","volume":"3","author":"Willuhn","year":"2010","journal-title":"Curr. Top Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib84","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev.ps.40.020189.001203","article-title":"Brain dopamine and reward","volume":"40","author":"Wise","year":"1989","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-3565(24)37186-1","article-title":"Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: an in vivo fast-cyclic voltammetry study","volume":"284","author":"Xi","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.11.015_bib86","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2013.04.044","article-title":"Upregulation of the dorsal raphe nucleus-prefrontal cortex serotonin system by chronic treatment with escitalopram in hyposerotonergic Wistar-Kyoto rats","volume":"72","author":"Yamada","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.015_bib87","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neulet.2005.02.026","article-title":"Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test","volume":"381","author":"Zomkowski","year":"2005","journal-title":"Neurosci. Lett."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818308505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818308505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:55:48Z","timestamp":1758437748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818308505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":89,"alternative-id":["S0028390818308505"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.11.015","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}